Adtalem Global Education Inc ATGE shares are trading higher by around 16% after the company reported better-than-expected Q1 FY24 results and issued FY24 guidance.
The company reported revenue growth of 4.1% Y/Y to $368.8 million, beating the consensus of $357.3 million, with student enrollment rising 1.9% Y/Y to 81,073.
Chamberlain University witnessed the third consecutive quarter of total enrollment growth (+5.2% Y/Y) on continued acceleration in pre-licensure and post-licensure nursing programs and high persistence.
On the other hand, Walden University enrollment returned to growth (+0.5% Y/Y) in Q1, led by an increase in healthcare programs and high persistence.
Adjusted EBITDA declined 3.8% Y/Y to $80.5 million, with margin contraction to 21.8% from 23.6% in Q3. Adjusted EPS of $0.93 beat the consensus of $0.80.
The company repurchased shares worth $92 million against an authorized share repurchase program of $300 million.
As of September 30, 2023, cash and cash equivalents stood at $262.4 million.
FY24 Outlook: Adtalem raised revenue guidance to $1.470 billion-$1.530 billion (from $1.460 billion to $1.520 billion earlier) vs. consensus of $1.48 billion. It expects adjusted EPS of $4.25 to $4.45 (from $4.20 to $4.40 earlier) vs street view of $4.31.
Also, Baird upgraded the stock to Outperform from Neutral and raised its price target to $55 from $47.
Price Action: ATGE shares are up 16.1% at $50.22 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.